Abstract-Microbial species thrive within human hosts by establishing complex associations between themselves and the host. Even though species diversity can be measured (alphaand beta-diversity), a methodology to estimate the impact of microorganisms in human pathways is still lacking. In this work we propose a computational approach to estimate which human pathways are targeted the most by microorganisms, while also identifying which microorganisms are prominent in this targeting. Our results were consistent with literature evidence, and thus we propose this methodology as a new prospective approach to be used for screening potentially impacted pathways.
I. INTRODUCTION
The human organism is an ecosystem harboring about ten times more microbial cells than its own somatic and germ cells. This was the motto behind The Human Microbiome Project (HMP), which was created in attempt to establish new parameters for health and disease [1] . The development and introduction of next generation sequencing techniques propelled the identification of the human microbiome (the sum of our microbial symbionts), which in turn allowed the characterization of microbial species by their gene products.
Microorganisms must establish protein-protein interactions (PPIs) with the host to be able to thrive [2] . Since each PPI complex has a defined output in physiological context, one can hypothesize that if a human protein is interacting with a microbial protein, the former will not be available to establish a complex with its physiological interacting counterpart [reviewed in 3] . This could negatively impact pathways of the host (e.g., [4] ), but positive impact is also a possibility (e.g., [5] ).
Even though the diversity of microbial communities, within and across samples (alpha-diversity and beta diversity, respectively) for various body sites, has already been described [6] , we did not find any approach to measure the potential positive or negative impact of microorganisms in human pathways. In this work we propose an algorithm to estimate the impact of microorganisms in human pathways. We tested our approach in ten different microbiomes, obtaining results consistent with the literature.
II. METHODS

A. Data Collection
Human gene data were obtained from the Human Protein Atlas [7] , and filtered according to its expression level -only genes considered as being highly expressed in a certain body site were taken into account. Microbial gene data were collected from HMP, including abundance scores for each sample.
Sample extraction site data were also collected to establish the baseline microbiomes for each body site. The UniProt accession IDs of each possible gene product from the obtained gene pool. Each microbial and human protein acquired this way was sorted into the body site where their respective precursor genes were originally found. A summary of the final ten microbiomes is shown in Table 1 .
After successful identification of the protein pool possibly present in each microbiome, we predicted the protein interactions most likely to occur in those sites (i.e., the interactome for each microbiome). This task was fulfilled by using an adaptation of a previously described methodology [8] by the same authors.
Human pathway data was retrieved from the Reactome database [9] . This includes the name of the pathway and of all the proteins present in the respective pathway. All data from the Human Protein Atlas, the HMP, and the Reactome database used in this work were downloaded in June 2014.
B. PPI Prediction Within Microbiomes
The PPI prediction approach used in this work was based in [8] . This methodology focused on five feature clusters constructed from: literature; primary protein sequence information; orthologous profiles; biological process similarity, and; enriched conserved domain pairs. These clusters were optimized for the prediction of PPIs in proteins with a high degree of annotation. The most general and descriptive feature cluster was based on protein sequence data, and since the sequences of all proteins in our datasets are known, this means our feature cluster has 100% data coverage. For this reason, we opted to optimize the original algorithm for sequence -based PPI predictions.
The final classifier was tested using 5-fold cross validation against a dataset of high-quality, experimentally identified, and manually curated protein interactions (approximately 20,000 PPIs). These data were obtained from the BioGRID database [10] in March, 2014. PPI predictions in this work were obtained with an average accuracy of 0.9.
B. Data clustering
The final pre-processing step involved clustering all organisms present by their respective phyla, so we can understand which phyla impacts each human pathway the most. We opted for a phylum-level analysis since we are analyzing ten different microbiomes. Indeed, this level of taxonomic resolution has been used in a recent related work [6] . Since avian, bovine, and porcine proteins were identified in our protein pool, we removed all proteins under the Animalia kingdom, as we believe many of these proteins could be considered sample contaminants present by the time of sample extraction.
Even though all the proteins present in our data set could be clustered in 24 different phyla, we chose to only analyze the impact of Actinobacteria, Bacteroidetes, Cyanobacteria, Firmicutes, Fusobacteria, Proteobacteria, Spirochaetes, and Tenericutes, as in these phyla are included the most notable human bacterial pathogens.
In addition, from a list of 201 human pathways that were targeted for interaction by at least one microbial protein, we chose to only analyze the ten pathways that were most targeted for PPIs by microbial proteins. The list of human pathways analyzed in this work is shown in Table 2 .
All the proteins that integrated any of the 201 pathways were cross-linked with the human proteins present in our dataset, for each body site. This resulted in a list that linked each event to the human proteins that were expressed in each region, together with the total number of proteins that participated in each event. In addition, sub-pathways were grouped by their respective parent pathways. As such, our analysis will fall on the apoptosis, cell cycle, DNA repair, gene expression, and metabolism pathways.
C. Calculating the Microbial Impact in Human Pathways
The main hypothesis behind the development of our algorithm was simple: if a microbial protein interacts with a human protein that is part of a pathway, one can expect a decrease in pathway activity downstream of the targeted protein, since the targeted protein is transiently occupied. Of course, this will depend on the abundance of both targeting (microbial) and target (human) proteins. With this in mind, we developed the following equation:
 
In brief, for the analysis of the level of impact (θ) induced to each event (e), we averaged the sum of the abundance (ω j ) of each microbial protein (j) by the total number of microbial proteins (m i ), which interact positively with each human protein (i). The value of m i represents the number of the most abundant microbial proteins which interact with each human protein of the total number of affected human proteins (h e ). This value is then weighted by the total number of human proteins (H e ) that participated in the event. For instance, when the total number of human proteins in any pathway p increases, one can expect a low impact θ p . This can be caused by possible compensatory mechanisms in pathway p, where an isoform of the targeted protein plays the role of the latter in the pathway, or even due to up-regulation of gene expression as part of a feedback mechanism [11, 12] . Finally, we proceeded to the quantitative estimation of the impact of each phylum in human pathways.
III. RESULTS AND DISCUSSION
A. Impact mapping Fig. 1 presents the results of our proposed approach. Regions with higher microbial abundance are easily spotted, as they have the highest impact values (the appendix, colon, oral mucosa, rectum, and small intestine). The other five body sites not only present lower impact values, but also seem to have dominant phyla.
In comparison with the appendix, colon, oral mucosa, rectum, and small intestine, these sites seem to possess reduced species diversity, as more than one phyla can be observed having an impact in the pathways of the former sites. Nonetheless, these results depend heavily on the extent of the knowledge of microbial genomes (and proteomes). That is, fully uncovered microbial proteomes will allow to optimize the prediction of protein interactions to a whole new level, enhancing all computational approaches based on such predictions.
B. Characterization of impact maps
We found that the phyla impacting the appendix, colon, rectum and small intestine (Fig. 1, Panels A, C, G, and I ) the most were Bacteroidetes, Firmicutes, and Proteobacteria. In addition, when compared with the other six microbiomes, these regions suffered the greatest microbial impact. Literature evidence shows that these phyla make up for almost all of the species in the gut microbiota [13] . Our results also show that the main human pathways being targeted by microbial proteins are apoptosis, gene expression, and metabolism. Indeed, we found evidence that the gut microbiota has been implicated in metabolic disturbances, such as obesity, outflow during energy production, and even the regulation of host genes that control metabolic processes [14, 15] .
Vaginal and cervical/uterine (Fig. 1 , Panels B and J) regions also show a very similar pattern. Both regions were dominated by Firmicutes, consistently with literature evidence [16] . In this microbiome, we identified cell cycle, metabolism and DNA repair as the pathways being impacted the most. Such results also have literature support, as some Lactobacilli species were shown to decelerate cell cycle progression in the cervix, while a single Lactobacillus species was found to transiently accelerate cellular division in the human host [17] .
The esophagus (Fig. 1, Panel D) possessed great microbial diversity, being mostly impacted by species under the Proteobacteria, Firmicutes, and Bacteroidetes phyla. The most affected pathways in the esophagus were metabolism and DNA repair, which according to existing literature, can occur once bacterial species activate their damage repair mechanisms. This will in turn induce DNA damage in the host, thus activating its DNA repair mechanisms [18, 19] .
The oral cavity and nasopharynx (Fig. 1 , Panels E and F) presented similar patterns, being impacted the most by Proteobacteria, Firmicutes, and Bacteroidetes. In this microbiome cell cycle was the pathway being targeted the most by microbial proteins. This may be explained by the ability of species like Aggregatibacter actinomycetemcomitans (under the Proteobacteria phylum) and Porphyromonas gingivalis (Firmicutes phylum), to induce cell cycle arrest, leading to the downregulation of host genes involved in cell cycle regulation [20, 21] .
Lastly, our findings showed that Actinobacteria, Firmicutes and Proteobacteria were the phyla with most impact on the skin cellular events (Fig. 1, Panel H) , which is consistent with the literature [22, 23] . We found that the pathways being targeted the most in this microbiome were cell cycle, metabolism and DNA repair. These are most likely explained by the presence of bacterial DNA in the host dermis, even when this DNA originates from dead bacteria [24, 25] . However, these studies were highly suggestive that bacterial cells can indeed colonize the dermis [26] .
IV. CONCLUSION
We believe one cannot consider the human being as an individual organism, but rather as a multitude. Indeed, it is clear that not only human cells and proteins should be considered when it comes to systems biology. Humans as an ecosystem are constantly evolving, and various intrinsic (e.g., ethnicity, age) and extrinsic factors (e.g., habits, physical activity, diet) contribute to the development and establishment of the microbiomes of each individual. In addition, the microbiomes of healthy individuals for the same body sites can be dissimilar, rendering the task of identifying baseline microbiomes extremely challenging.
We should also emphasize that knowing which proteins in human pathways are being targeted by microbial proteins may provide new grounds for the research of specific microbial pathogenesis mechanisms. This knowledge would prove of utmost interest to the pharmacological and clinical research areas, as it could be used for the development of new drugs and diagnostic methods.
The proposed algorithm consists of a first approach to systematically analyze the impact of microbial communities in humans. Based on the high degree of consistency between the obtained results and the existing literature, we believe the herein proposed algorithm has been successful in identifying events that actually occur in vivo.
